FSD Pharma Inc. [NASDAQ: HUGE] traded at a high on 11/13/20, posting a 8.63 gain after which it closed the day’ session at $1.51. The company report on November 13, 2020 that FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update.
FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announced its financial results for the third quarter ending September 30, 2020 and provided a corporate update. The filing is available on SEDAR.
Financial and corporate highlights include:.
The results of the trading session contributed to over 3172995 shares changing hands. Over the past one week, the price volatility of FSD Pharma Inc. stands at 16.06% while the volatility over the past one month is 11.46%.
The market cap for HUGE stock reached $28.93 million, with 19.16 million shares outstanding and 6.81 million shares in the current float. Compared to the average trading volume of 441.74K shares, HUGE reached a trading volume of 3172995 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about FSD Pharma Inc. [HUGE]?
The Average True Range (ATR) for FSD Pharma Inc. is set at 0.18
How has HUGE stock performed recently?
FSD Pharma Inc. [HUGE] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -0.66. With this latest performance, HUGE shares dropped by -41.02% in over the last four-week period, additionally sinking by -54.93% over the last 6 months – not to mention a drop of -72.14% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HUGE stock in for the last two-week period is set at 34.69, with the RSI for the last a single of trading hit 41.69, and the three-weeks RSI is set at 33.72 for FSD Pharma Inc. [HUGE]. The present Moving Average for the last 50 days of trading for this stock 2.2329, while it was recorded at 1.4400 for the last single week of trading, and 3.4070 for the last 200 days.
FSD Pharma Inc. [HUGE]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and FSD Pharma Inc. [HUGE] shares currently have an operating margin of -13869.84 and a Gross Margin at -1909.14. FSD Pharma Inc.’s Net Margin is presently recorded at -20230.80.
Return on Total Capital for HUGE is now -70.36, given the latest momentum, and Return on Invested Capital for the company is -104.65. Return on Equity for this stock declined to -104.81, with Return on Assets sitting at -94.38. When it comes to the capital structure of this company, FSD Pharma Inc. [HUGE] has a Total Debt to Total Equity ratio set at 4.38. Additionally, HUGE Total Debt to Total Capital is recorded at 4.19, with Total Debt to Total Assets ending up at 3.68. Long-Term Debt to Equity for the company is recorded at 0.30, with the Long-Term Debt to Total Capital now at 0.29.
Reflecting on the efficiency of the workforce at the company, FSD Pharma Inc. [HUGE] managed to generate an average of -$2,261,443 per employee. Receivables Turnover for the company is 0.17 with a Total Asset Turnover recorded at a value of 0.00.
Insider trade positions for FSD Pharma Inc. [HUGE]
There are presently around $0 million, or 0.51% of HUGE stock, in the hands of institutional investors. The top three institutional holders of HUGE stocks are: WEDBUSH SECURITIES INC with ownership of 64,300, which is approximately 158.628% of the company’s market cap and around 16.40% of the total institutional ownership; UBS GROUP AG, holding 4,853 shares of the stock with an approximate value of $7000.0 in HUGE stocks shares; and ROYAL BANK OF CANADA, currently with $4000.0 in HUGE stock with ownership of nearly 231.773% of the company’s market capitalization.
Positions in FSD Pharma Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 7 institutional holders increased their position in FSD Pharma Inc. [NASDAQ:HUGE] by around 46,404 shares. Additionally, 4 investors decreased positions by around 381 shares, while 1 investors held positions by with 29,972 shares. The mentioned changes placed institutional holdings at 76,757 shares, according to the latest SEC report filing. HUGE stock had 3 new institutional investments in for a total of 3,247 shares, while 2 institutional investors sold positions of 123 shares during the same period.